GeneFerm Biotechnology (Taiwan) Today
| 1796 Stock | TWD 49.95 0.45 0.89% |
Performance2 of 100
| Odds Of DistressLess than 9
|
GeneFerm Biotechnology is selling for under 49.95 as of the 28th of November 2024; that is 0.89 percent decrease since the beginning of the trading day. The stock's lowest day price was 49.95. GeneFerm Biotechnology has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for GeneFerm Biotechnology Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented products in Taiwan and internationally. The company was founded in 1999 and is based in Taipei City, Taiwan. GENEFERM BIOTECHNOLOGY operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.. The company has 41.46 M outstanding shares. More on GeneFerm Biotechnology Co
Moving against GeneFerm Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
GeneFerm Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. GeneFerm Biotechnology's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding GeneFerm Biotechnology or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Biotech (View all Themes) |
| Business Concentration | Biotech, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
GeneFerm Biotechnology Co (1796) is traded on Taiwan OTC Exchange in Taiwan and employs 12 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GeneFerm Biotechnology's market, we take the total number of its shares issued and multiply it by GeneFerm Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GeneFerm Biotechnology operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 41.46 M outstanding shares.
GeneFerm Biotechnology Co has accumulated about 619.1 M in cash with 112.23 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.32.
Check GeneFerm Biotechnology Probability Of Bankruptcy
Ownership AllocationGeneFerm Biotechnology Co has a total of 41.46 Million outstanding shares. GeneFerm Biotechnology secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GeneFerm Ownership Details
GeneFerm Biotechnology Risk Profiles
Although GeneFerm Biotechnology's alpha and beta are two of the key measurements used to evaluate GeneFerm Biotechnology's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.35 | |||
| Semi Deviation | 1.81 | |||
| Standard Deviation | 2.02 | |||
| Variance | 4.06 |
GeneFerm Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in GeneFerm Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
GeneFerm Biotechnology Corporate Management
Elected by the shareholders, the GeneFerm Biotechnology's board of directors comprises two types of representatives: GeneFerm Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GeneFerm. The board's role is to monitor GeneFerm Biotechnology's management team and ensure that shareholders' interests are well served. GeneFerm Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GeneFerm Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frank Hsiao | Deputy General Manager-Sales & Marketing Division | Profile | |
| Qimian Su | Head of Finance & Accounting | Profile | |
| Zongmin Chen | Independent Director | Profile | |
| Grance Chang | Chairman of the Board | Profile | |
| Benlin Chen | Director | Profile | |
| Yiren Ji | Director | Profile | |
| Jiajun Hong | Director | Profile |
Additional Tools for GeneFerm Stock Analysis
When running GeneFerm Biotechnology's price analysis, check to measure GeneFerm Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneFerm Biotechnology is operating at the current time. Most of GeneFerm Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneFerm Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneFerm Biotechnology's price. Additionally, you may evaluate how the addition of GeneFerm Biotechnology to your portfolios can decrease your overall portfolio volatility.